Elevated expression of activins promotes muscle wasting and cachexia
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elevated expression of activins promotes muscle wasting and cachexia
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 28, Issue 4, Pages 1711-1723
Publisher
FASEB
Online
2013-12-31
DOI
10.1096/fj.13-245894
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TWEAK and TRAF6 regulate skeletal muscle atrophy
- (2012) Ashok Kumar et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin
- (2012) Catherine E. Winbanks et al. JOURNAL OF CELL BIOLOGY
- Understanding the mechanisms and treatment options in cancer cachexia
- (2012) Kenneth Fearon et al. Nature Reviews Clinical Oncology
- Targeting the TGFβ signalling pathway in disease
- (2012) Rosemary J. Akhurst et al. NATURE REVIEWS DRUG DISCOVERY
- Molecular Mechanisms and Treatment Options for Muscle Wasting Diseases
- (2011) Markus A. Rüegg et al. Annual Review of Pharmacology and Toxicology
- Dimethylarginine Dimethylaminohydrolase-1 Is the Critical Enzyme for Degrading the Cardiovascular Risk Factor Asymmetrical Dimethylarginine
- (2011) Xinli Hu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Generation of a Specific Activin Antagonist by Modification of the Activin A Propeptide
- (2011) Yogeshwar Makanji et al. ENDOCRINOLOGY
- Prodomains regulate the synthesis, extracellular localisation and activity of TGF-β superfamily ligands
- (2011) Craig A. Harrison et al. GROWTH FACTORS
- TGF-β Regulates miR-206 and miR-29 to Control Myogenic Differentiation through Regulation of HDAC4
- (2011) Catherine E. Winbanks et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptor
- (2011) Fedik Rahimov et al. PHYSIOLOGICAL GENOMICS
- Treating cancer cachexia to treat cancer
- (2011) Se-Jin Lee et al. Skeletal Muscle
- Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
- (2010) Xiaolan Zhou et al. CELL
- Interleukin 6 as a Key Regulator of Muscle Mass during Cachexia
- (2010) James A. Carson et al. EXERCISE AND SPORT SCIENCES REVIEWS
- The TWEAK–Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice
- (2010) Ashwani Mittal et al. JOURNAL OF CELL BIOLOGY
- PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of Akt
- (2009) Tatsuya Kawase et al. CELL
- A new ‘total’ activin B enzyme-linked immunosorbent assay (ELISA): development and validation for human samples
- (2009) Helen Ludlow et al. CLINICAL ENDOCRINOLOGY
- A Common Biosynthetic Pathway Governs the Dimerization and Secretion of Inhibin and Related Transforming Growth Factor β (TGFβ) Ligands
- (2009) Kelly L. Walton et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of the Intracellular Localization of Foxo3a by Stress-Activated Protein Kinase Signaling Pathways in Skeletal Muscle Cells
- (2009) S. Clavel et al. MOLECULAR AND CELLULAR BIOLOGY
- Mechanisms of Cancer Cachexia
- (2009) Michael J. Tisdale PHYSIOLOGICAL REVIEWS
- Translation elongation factor eEF1A binds to a novel myosin binding protein-C-like protein
- (2008) Francisco Mansilla et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started